| Management of perioperative hypertensive urgencies with parenteral medications. | |
| | |
MedLine Citation:
|
PMID: 20104635 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Hypertension is the major risk factor for cardiovascular (CV) disease such as myocardial infarction (MI) and stroke. This risk is well known to extend into the perioperative period. Although most perioperative hypertension can be managed with the patient's outpatient regimen, there are situations in which oral medications cannot be administered and parenteral medications become necessary. They include postoperative nil per os status, severe pancreatitis, and mechanical ventilation. This article reviews the management of perioperative hypertensive urgency with parenteral medications. METHODS: A PubMed search was conducted by cross-referencing the terms "perioperative hypertension," "hypertensive urgency," "hypertensive emergency," "parenteral anti-hypertensive," and "medication." The search was limited to English-language articles published between 1970 and 2008. Subsequent PubMed searches were performed to clarify data from the initial search. RESULTS: As patients with hypertensive urgency are not at great risk for target-organ damage (TOD), continuous infusions that require intensive care unit (ICU) monitoring and intraarterial catheters seem to be unnecessary and a possible misuse of resources. CONCLUSIONS: When oral therapy cannot be administered, patients with hypertensive urgency can have their blood pressure (BP) reduced with hydralazine, enalaprilat, metoprolol, or labetalol. Due to the scarcity of comparative trials looking at clinically significant outcomes, the medication should be chosen based on comorbidity, efficacy, toxicity, and cost. |
| | |
Authors:
|
Kartikya Ahuja; Mitchell H Charap |
Related Documents
:
|
15560445 - Medical waste management in trachea region of turkey: suggested remedial action. 10157565 - Life expectancy projection benchmarks: a how-to guide for medical equipment replacement... 12608525 - Treatment of obesity: an update on anti-obesity medications. 10868325 - Anesthesia for electroconvulsive therapy: a review. 10537865 - Polypharmacy management in medicare managed care: changes in prescribing by primary car... 17146675 - Teaching hematology to second year medical students: results of a national survey of he... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of hospital medicine : an official publication of the Society of Hospital Medicine Volume: 5 ISSN: 1553-5606 ISO Abbreviation: J Hosp Med Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-01 Completed Date: 2010-05-04 Revised Date: 2010-06-30 |
Medline Journal Info:
|
Nlm Unique ID: 101271025 Medline TA: J Hosp Med Country: United States |
Other Details:
|
Languages: eng Pagination: E11-6 Citation Subset: IM |
Affiliation:
|
Division of Cardiology, Albert Einstein College of Medicine, Bronx, New York 10461, USA. kahuja@montefiore.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
administration & dosage,
adverse effects,
economics Humans Hypertension / complications, drug therapy* Infusions, Parenteral* Perioperative Care / organization & administration* |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Examining guideline-concordant care for acute myocardial infarction (AMI): The case of hospitalized ...
Next Document: Hypercalcemia and acute renal failure in milk-alkali syndrome: A case report.